Inovio Pharmaceuticals (INO) Goodwill (2010 - 2023)

Inovio Pharmaceuticals has disclosed Goodwill across 14 years of filings, most recently posting $10.5 million for Q2 2023.

• In Q2 2023, Goodwill changed 0.0% year-over-year to $10.5 million; the TTM figure through Jun 2023 stood at $10.5 million (changed 0.0% YoY), while the FY2022 annual figure was $10.5 million, changed 0.0% from the prior year.
• Goodwill came in at $10.5 million for Q2 2023 at Inovio Pharmaceuticals, roughly flat from $10.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $10.5 million in Q1 2019 to a low of $10.5 million in Q1 2019.
• Average Goodwill over 5 years is $10.5 million, with a median of $10.5 million recorded in 2019.
• The largest YoY upside for Goodwill was 0.0% in 2019 against a maximum downside of 0.0% in 2019.
• Over 5 years, Goodwill stood at $10.5 million in 2019, then changed by 0.0% to $10.5 million in 2020, then changed by 0.0% to $10.5 million in 2021, then changed by 0.0% to $10.5 million in 2022, then changed by 0.0% to $10.5 million in 2023.
• Per Business Quant data, the three most recent Goodwill figures were $10.5 million in Q2 2023, $10.5 million in Q1 2023, and $10.5 million in Q4 2022.